U.S. flag

An official website of the United States government

NM_000157.4(GBA1):c.685G>A (p.Ala229Thr) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 14, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003482469.1

Allele description [Variation Report for NM_000157.4(GBA1):c.685G>A (p.Ala229Thr)]

NM_000157.4(GBA1):c.685G>A (p.Ala229Thr)

Genes:
LOC106627981:GBA recombination region [Gene]
GBA1:glucosylceramidase beta 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q22
Genomic location:
Preferred name:
NM_000157.4(GBA1):c.685G>A (p.Ala229Thr)
Other names:
p.Ala229Thr
HGVS:
  • NC_000001.11:g.155238210C>T
  • NG_009783.1:g.11488G>A
  • NG_042867.1:g.4672C>T
  • NM_000157.4:c.685G>AMANE SELECT
  • NM_001005741.3:c.685G>A
  • NM_001005742.3:c.685G>A
  • NM_001171811.2:c.424G>A
  • NM_001171812.2:c.538G>A
  • NP_000148.2:p.Ala229Thr
  • NP_001005741.1:p.Ala229Thr
  • NP_001005742.1:p.Ala229Thr
  • NP_001165282.1:p.Ala142Thr
  • NP_001165283.1:p.Ala180Thr
  • NC_000001.10:g.155208001C>T
Protein change:
A142T
Molecular consequence:
  • NM_000157.4:c.685G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005741.3:c.685G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005742.3:c.685G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171811.2:c.424G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171812.2:c.538G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004228185Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Apr 14, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot providednot providednot providedclinical testing

Citations

PubMed

Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.

Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E.

Hum Mutat. 2000;15(2):181-8. Review.

PubMed [citation]
PMID:
10649495

Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.

Koprivica V, Stone DL, Park JK, Callahan M, Frisch A, Cohen IJ, Tayebi N, Sidransky E.

Am J Hum Genet. 2000 Jun;66(6):1777-86. Epub 2000 May 4.

PubMed [citation]
PMID:
10796875
PMCID:
PMC1378059
See all PubMed Citations (5)

Details of each submission

From Mayo Clinic Laboratories, Mayo Clinic, SCV004228185.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (5)

Description

PP4, PM2, PM3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

Last Updated: Jan 26, 2024